Understanding mechanisms of hypertension in systemic lupus erythematosus

39Citations
Citations of this article
105Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder that predominately affects women of reproductive age. Hypertension is an important cardiovascular risk factor that is prevalent in this patient population. Despite the high incidence of hypertension in women with SLE, the pathophysiological mechanisms underlying the development of hypertension remain poorly understood. This review will focus on disease-related factors, including inflammation, autoantibodies, and sex hormones that may contribute to hypertension in patients with SLE. In addition, we will highlight studies performed by our laboratory using the female NZBWF1 (F1 hybrid of New Zealand Black and New Zealand White strains) mouse model, a spontaneous model of SLE that mimics human disease and develops hypertension and renal injury. Specifically, using female NZBWF1 mice, we have demonstrated that multiple factors contribute to the pathogenesis of hypertension, including the inflammatory cytokine, tumor necrosis factor (TNF)-α, oxidative stress, as well as B-cell hyperactivity and autoantibody production.

Cite

CITATION STYLE

APA

Taylor, E. B., & Ryan, M. J. (2017, January 1). Understanding mechanisms of hypertension in systemic lupus erythematosus. Therapeutic Advances in Cardiovascular Disease. SAGE Publications Ltd. https://doi.org/10.1177/1753944716637807

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free